Cargando…

Psychosis research in Asia: advantage from low prevalence of cannabis use

Detalles Bibliográficos
Autores principales:	Lee, Tae Young, Kwon, Jun Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441311/ https://www.ncbi.nlm.nih.gov/pubmed/28560246 http://dx.doi.org/10.1038/s41537-016-0002-4

Ejemplares similares

Research Trends in Individuals at High Risk for Psychosis: A Bibliometric Analysis
por: Lee, Tae Young, et al.
Publicado: (2022)

Impact of cannabis use and cannabis cessation on inflammation in patients with psychosis
por: Romeo, B., et al.
Publicado: (2023)

Cannabis and psychosis: Neurobiology
por: Shrivastava, Amresh, et al.
Publicado: (2014)

Cannabis Induced Psychosis
por: Bramness, J.
Publicado: (2022)

Prevalence and Risk Factors of Irritable Bowel Syndrome in Asia
por: Lee, Oh Young
Publicado: (2010)

Prevalence of cannabis use in people with psychosis in KwaZulu-Natal, South Africa
por: Mona, Khanya, et al.
Publicado: (2022)

Introduction to Cannabis and Cannabinoid Research
por: Piomelli, Daniele
Publicado: (2016)

Advantages and limitations of using national survey datasets in child and adolescent research
por: Lee, Yoon
Publicado: (2021)

Connect medical education practices and research in Asia with the rest of world
por: Lee, Young-Mee
Publicado: (2017)

Sensorimotor gating, cannabis use and the risk of psychosis
por: Winton-Brown, T., et al.
Publicado: (2015)

Emerging Topics and Innovative Methodologies in Cannabis Research
por: Albright, Victoria A, et al.
Publicado: (2018)

Three Decades of Cannabis Research: What are the Obstacles?
por: Dor, Michael
Publicado: (2022)

Early onset of cannabis use and violent behavior in psychosis
por: Moulin, Valerie, et al.
Publicado: (2020)

Cannabis use during first episode psychosis in Tunisia
por: Bergaoui, E., et al.
Publicado: (2023)

Cannabis and psychosis: what causes what?
por: Castle, David J
Publicado: (2013)

Supplements used to advantage
por: Wall, Stig, et al.
Publicado: (2010)

Two cases of "cannabis acute psychosis" following the administration of oral cannabis
por: Favrat, Bernard, et al.
Publicado: (2005)

Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis
por: Bortoletto, Riccardo, et al.
Publicado: (2022)

Pathways from Cannabis to Psychosis: A Review of the Evidence
por: Burns, Jonathan K.
Publicado: (2013)

Cannabis-related psychosis: Presentation and effect of abstinence
por: Kulhalli, Vani, et al.
Publicado: (2007)

Cannabis and Psychosis Through the Lens of DSM-5
por: Pearson, Nathan T., et al.
Publicado: (2019)

Monitoring the impact of cannabis use
por: Le Foll, Bernard
Publicado: (2022)

Priority areas for cannabis and cannabinoid product research in South Africa
por: Augustine, Tanya N., et al.
Publicado: (2018)

State-of-the-Art Chronic Hepatitis Viruses Research in Asia
por: Chien, Rong-Nan
Publicado: (2023)

Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis
por: Sami, Musa, et al.
Publicado: (2020)

Can we interrogate public databases to fill critical gaps in mental health epidemiology? Testing the association between cannabis and psychosis in the UK as an example
por: Di Gennaro, Gianfranco, et al.
Publicado: (2023)

Association between cannabis use and symptoms of psychosis: a mega-analysis
por: Argote, M., et al.
Publicado: (2023)

Medicinal Cannabis and Synthetic Cannabinoid Use
por: Pichini, Simona, et al.
Publicado: (2020)

Cannabis and Psychosis: Are We any Closer to Understanding the Relationship?
por: Hamilton, Ian, et al.
Publicado: (2019)

Minimizing policy-biased appraisals of the evidence on cannabis and psychosis
por: Hall, Wayne
Publicado: (2023)

Pattern of predictive features of continued cannabis use in patients with recent-onset psychosis and clinical high-risk for psychosis
por: Penzel, Nora, et al.
Publicado: (2022)

Phytochemical and genetic analyses of ancient cannabis from Central Asia
por: Russo, Ethan B., et al.
Publicado: (2008)

Impaired Performance on the Reading the Mind in the Eyes Test in First-Episode Psychosis and Clinical High Risk for Psychosis
por: Kim, Seo Woo, et al.
Publicado: (2020)

PM504. Theory of Mind in Clinical high risk as trait marker of conversion to psychosis: review
por: Suh, Jee-Hyung, et al.
Publicado: (2016)

Regional and international collaboration: key to quality research in south Asia
por: The Lancet Regional Health – Southeast Asia
Publicado: (2023)

Advantages of ocular regeneration research
por: Park, Susanna S.
Publicado: (2021)

Prevalence of Irritable Bowel Syndrome in East Asia: Are There Differences Between Countries?
por: Shin, Cheol Min
Publicado: (2023)

Risk factors for cannabis use disorders and cannabis psychosis in Japan: Second report of a survey on cannabis‐related health problems among community cannabis users using social networking services
por: Masataka, Yuji, et al.
Publicado: (2022)

Evidence for using pimavanserin for the treatment of Parkinson's disease psychosis
por: Tampi, Rajesh R, et al.
Publicado: (2019)

Risk factors for the onset of dependence and chronic psychosis due to cannabis use: Survey of patients with cannabis‐related psychiatric disorders
por: Matsumoto, Toshihiko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g67l3aopoog2gfgh7gp87he6kc